Abstract |
Three monoclonal antibodies, designated FP-1, FP-2 and FP-3, were obtained by immunizing a BALB/c mouse with dispersed human fetal pancreatic cells and using hybridoma technology. FP-1, FP-2 and FP-3 reacted specifically, respectively, with the ductal epithelial, acinar and islet cells, of the fetal pancreas as well as with adult human pancreatic tissue, suggesting a use in the discrimination of pancreatic cell types. Upon screening various tumor tissues, FP-1 was found to react with adenocarcinomas of the pancreas (16/23), stomach (7/8), colon (4/6) and gall bladder (2/2) as well as with the three malignant cell lines, PANC-1 (pancreas), HT-29 (colon) and LoVo (colon). In contrast to FP-1, FP-2 and FP-3 reacted with only 5% (2/39) and 0% (0/39), respectively, of these adenocarcinomas. Although FP-3 did not react with any of these adenocarcinomas, it did react with various APUDoma cells such as islet cell tumors of the pancreas (3/5), pheochromocytomas (2/2), medullary thyroid carcinomas (2/3) and gastrointestinal carcinoids (1/3). FP-3 thus appears to be the first monoclonal antibody with extremely high endocrine cell specificity.
|
Authors | K Shibata, T Kobayashi, N Matsuura, T Shimano, T Mori |
Journal | Japanese journal of clinical oncology
(Jpn J Clin Oncol)
Vol. 21
Issue 1
Pg. 13-21
(Feb 1991)
ISSN: 0368-2811 [Print] England |
PMID | 1648632
(Publication Type: Journal Article)
|
Chemical References |
- Antibodies, Monoclonal
- Antigens, Neoplasm
- oncofetal antigens
|
Topics |
- Animals
- Antibodies, Monoclonal
(biosynthesis)
- Antibody Specificity
- Antigens, Neoplasm
(immunology)
- Carcinoma
(immunology)
- Carcinoma, Intraductal, Noninfiltrating
(immunology)
- Clone Cells
- Humans
- Hybridomas
- Immunoenzyme Techniques
- Immunohistochemistry
- Mice
- Mice, Inbred BALB C
- Pancreas
(embryology, immunology)
- Pancreatic Neoplasms
(immunology)
|